Injection Devices for Self Administration


injection devices for self administration   Published April 2016  •  Catalog no. JDS588R  •  Price US $3,850


An increasing number of injectable drugs are being developed for long-term self-administration and represent the first group of injectables that are being designed with the end user in mind. These drugs are the first beyond insulin and vaccines to limit packaging in vials in favor of prefilled specialty injection devices. For drug self-administration devices, human engineering and user ergonomics are essential attributes that impact critical patient issues such as safety and patient compliance. While designers have acquired many powerful design tools during the past decade – tools that include 3D CAD design software and high performance materials – design team have been increasingly relying on classic end user research to define the design targets for their projects.

Bar_Graph  Report Prospectus (Download PDF)

Blue document  Report Order Form (Download PDF)


Injection Devices for Self Administration – What You Will Learn

  • What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving device designs focusing on self-administration?
  • What are the market drivers influencing syringe and injector device designs, feature/functionality, product branding, competing technologies and commercial development?
  • What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
  • What is the current market for self-injectable device demand by indication and therapy and what will it be in the next eight years?
  • Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
  • What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?

Injection Devices for Self Administration – Summary of Contents

Executive Summary

The Market Opportunity

Delivery Market Dynamics
The Economics of Injectable Drugs
What’s Driving the Growth in Self-Administration?
Prefilled Devices Proliferating
Shifting Demographics
Innovation in Disposable Device Designs
Chronic Conditions Proliferating
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Device Design and Technology

Human Engineering/Ergonomics
Material Selection Issues
Part Counts and Device Cost
Safety Features
Lyophilized Drugs and Reconstitution
High Viscosity Drug Delivery
Wireless Connectivity/Caregiver Awareness

Injection Devices for Self-Administration

Automated Injection Event
Autoinjectors
Prefilled Syringe Compatible
Cartridge-based
Pen Injectors
Custom/Branded Pens
OEM Pen Injectors
Needle-free Injectors
Specialty Injection Devices
Wearable Injectors
Patch Pumps
Wearable Infusion Devices

Self Injection Devices – Therapeutic Sector Analysis

Anaphylaxis/Countermeasures
Anticoagulants
Autoimmune Diseases
Chronic Viral Infections
Hematopoietics
Hormones
Metabolic Conditions
Diabetes
Osteoporosis
Neurology
Reproductive Health

Market Factors

Regulatory Issues
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles